Together we will beat cancer

Donate

An existing blood test for ovarian cancer has been re-evaluated. The results are in

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

Read More

Science Surgery: ‘How are children’s cancers different from adults’ cancers?’

This entry is part 22 of 22 in the series Science Surgery

Understanding why children get cancer is a huge task and extremely complex. In our latest Science Surgery, we spoke with Dr Francis Mussai about the differences between children and adult’s cancers.

Read More

More diversity is needed in patient information and campaigns

We spoke to Siobhan, Nikki and Jessica about their experiences of childhood cancer.

Read More

The changing landscape of children’s cancer treatment

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.

Read More

Grandparents of children with cancer: “I would never want to go through it again”

As part of Childhood Cancer Awareness Month, we spoke to 3 grandparents about their experience of having a grandchild with cancer.

Read More

The team tackling the serious side effects of cancer treatment in an ageing population

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.

Read More

US lung cancer data points to the power of cancer research

New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.

Read More

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

Read More

Cytosponge: A ‘sponge on a string’ test to detect oesophageal cancer earlier

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.

Read More

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

Read More